{"id":2335,"company":{"country":"US","currency":"USD","exchange":"NEW YORK STOCK EXCHANGE, INC.","ipo":"2000-09-29","marketCap":3252.014404296875,"name":"Integer Holdings Corp","phone":"12146185243","outstanding":33.33000183105469,"symbol":"ITGR","website":"https://integer.net","industry":"Health Care"},"price":96.925,"year":2023,"month":12,"day":16,"weekday":"Saturday","title":"Historical Stock Price Performance of Integer Holdings Corp","date":"2023-12-16","url":"/posts/2023/12/16/ITGR","content":[{"section":"2008 Financial Crisis","text":"During the 2008 Financial Crisis, Integer Holdings Corp experienced a significant decline in its stock price. From January 2008 to March 2009, the stock price dropped from around $40 per share to approximately $10 per share. This decline was driven by widespread market instability and concerns about the global economy."},{"section":"Post-Recession Recovery","text":"Following the recession, Integer Holdings Corp's stock price gradually recovered as market conditions improved. From 2009 to 2013, the stock price consistently increased, reaching a high of over $80 per share in early 2013. This recovery was influenced by improved economic indicators and increased investor confidence."},{"section":"COVID-19 Pandemic","text":"The COVID-19 pandemic, which triggered global economic uncertainty, had a mixed impact on Integer Holdings Corp's stock price. In the initial phase of the pandemic, from February to March 2020, the stock price experienced a significant drop, falling from around $80 per share to approximately $50 per share. This decline was driven by fears of an economic recession and disrupted supply chains."},{"section":"Market Rally \u0026 Vaccine Development","text":"As market optimism and vaccine development progressed, Integer Holdings Corp's stock price rebounded during the latter part of 2020 and early 2021. From April 2020 to February 2021, the stock price surged from around $50 per share to over $100 per share. This rally was fueled by positive market sentiment surrounding the recovery prospects and expectations of increased demand for healthcare products."},{"section":"Volatility in 2022","text":"In 2022, Integer Holdings Corp's stock price experienced increased volatility due to various factors. From February to June 2022, the stock price fluctuated between $90 and $120 per share. This volatility was influenced by market uncertainties, inflation concerns, and changes in investor sentiment. It's important to note that stock prices can be affected by a multitude of factors and can fluctuate on a daily basis."}],"tags":["CrossOver100","Long","Health Care"],"news":[{"category":"company","date":1702653420,"headline":"Here's Why You Should Retain Catalent (CTLT) Stock for Now","id":124543663,"image":"https://media.zenfs.com/en/zacks.com/c8704ffaba0234da981fa842a48f77b5","symbol":"ITGR","publisher":"Yahoo","summary":"Catalent's (CTLT) products and services portfolio and technology foundation raise optimism about the stock.","url":"https://finance.yahoo.com/news/heres-why-retain-catalent-ctlt-151700613.html"},{"category":"company","date":1702651207,"headline":"Why Integer (ITGR) is a Top Value Stock for the Long-Term","id":124544238,"image":"https://media.zenfs.com/en/zacks.com/a7cdcede0bb5a646be035f4a7e678781","symbol":"ITGR","publisher":"Yahoo","summary":"The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.","url":"https://finance.yahoo.com/news/why-integer-itgr-top-value-144007776.html"},{"category":"company","date":1702483020,"headline":"Integer Holdings (ITGR) Hits 52-Week High: What's Aiding It?","id":124494856,"image":"https://media.zenfs.com/en/zacks.com/c8704ffaba0234da981fa842a48f77b5","symbol":"ITGR","publisher":"Yahoo","summary":"Investors are optimistic about Integer Holdings' (ITGR) solid foothold in the broader MedTech space.","url":"https://finance.yahoo.com/news/integer-holdings-itgr-hits-52-155700231.html"},{"category":"company","date":1702476906,"headline":"Integer Holdings Corporation (ITGR) Hit a 52 Week High, Can the Run Continue?","id":124487815,"image":"https://media.zenfs.com/en/zacks.com/48ad4265c55e3ba7a1fb9148d6e717d9","symbol":"ITGR","publisher":"Yahoo","summary":"Integer (ITGR) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.","url":"https://finance.yahoo.com/news/integer-holdings-corporation-itgr-hit-141506807.html"},{"category":"company","date":1702450680,"headline":"Wells Fargo Sticks to Its Hold Rating for Integer Holdings (ITGR)","id":124493474,"image":"","symbol":"ITGR","publisher":"TipRanks","summary":"Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.","url":"https://www.zacks.com/research/get_news.php?id=3254922265"},{"category":"company","date":1702399320,"headline":"Masimo's (MASI) ORi Favored by Study for PaO2 Information","id":124466653,"image":"https://media.zenfs.com/en/zacks.com/b35c1538fbd501bfb8e20b349661fde7","symbol":"ITGR","publisher":"Yahoo","summary":"Masimo's (MASI) latest study indicates that ORi can be a valuable tool to provide information on arterial oxygenation even during OLV.","url":"https://finance.yahoo.com/news/masimos-masi-ori-favored-study-164200072.html"},{"category":"company","date":1702398660,"headline":"Here's Why You Should Retain Surmodics (SRDX) Stock for Now","id":124462672,"image":"https://media.zenfs.com/en/zacks.com/6e7a581172a57923b1e9381146e28fb5","symbol":"ITGR","publisher":"Yahoo","summary":"Surmodics' (SRDX) solid prospects in the thrombectomy business raise optimism about the stock.","url":"https://finance.yahoo.com/news/heres-why-retain-surmodics-srdx-163100076.html"},{"category":"company","date":1702308300,"headline":"Why You Should Retain Merit Medical (MMSI) Stock for Now","id":124441643,"image":"https://media.zenfs.com/en/zacks.com/c8704ffaba0234da981fa842a48f77b5","symbol":"ITGR","publisher":"Yahoo","summary":"Merit Medical's (MMSI) strong product portfolio raises optimism about the stock.","url":"https://finance.yahoo.com/news/why-retain-merit-medical-mmsi-152500841.html"},{"category":"company","date":1702308240,"headline":"McKesson (MCK) Announces Availability of FDA-Approved Drug","id":124441244,"image":"https://media.zenfs.com/en/zacks.com/41b7bdd28f63138df08f17b665d3589a","symbol":"ITGR","publisher":"Yahoo","summary":"The availability of the FDA-approved drug via McKesson's (MCK) independent specialty pharmacy is expected to give patients more treatment options for desmoid tumors.","url":"https://finance.yahoo.com/news/mckesson-mck-announces-availability-fda-152400131.html"},{"category":"company","date":1702290000,"headline":"Citi entering 2024 'cautiously optimistic' on U.S. MedTech companies","id":124438856,"image":"","symbol":"ITGR","publisher":"Thefly.com","summary":"Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.","url":"https://www.zacks.com/research/get_news.php?id=3251531389"},{"category":"company","date":1702289820,"headline":"Citi entering 2024 'cautiously optimistic' on U.S. MedTech companiesZimmer Biomet","id":124438857,"image":"","symbol":"ITGR","publisher":"Thefly.com","summary":"Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.","url":"https://www.zacks.com/research/get_news.php?id=3251527743"},{"category":"company","date":1702062900,"headline":"BD's (BDX) Novel Blood Collection System MiniDraw Gets FDA Nod","id":124405285,"image":"https://media.zenfs.com/en/zacks.com/62b53c8baa0ab2c805e2a16ae76ef3b8","symbol":"ITGR","publisher":"Yahoo","summary":"BD's (BDX) FDA approval for MiniDraw will likely reshape diagnostic testing by providing a unique design that offers blood collection at any convenient location with reduced volume.","url":"https://finance.yahoo.com/news/bds-bdx-novel-blood-collection-191500578.html"},{"category":"company","date":1702052340,"headline":"AMN Healthcare's (AMN) New Tie-Up to Boost Patient Outcome","id":124392370,"image":"https://media.zenfs.com/en/zacks.com/228e67967b066e7a755ae3614be720e1","symbol":"ITGR","publisher":"Yahoo","summary":"AMN Healthcare's (AMN) collaboration is likely to bolster its portfolio of products and simplify the language procurement process for customers.","url":"https://finance.yahoo.com/news/amn-healthcares-amn-tie-boost-161900538.html"},{"category":"company","date":1701962400,"headline":"Here's Why You Should Retain OPKO Health (OPK) Stock for Now","id":124366633,"image":"https://media.zenfs.com/en/zacks.com/c8704ffaba0234da981fa842a48f77b5","symbol":"ITGR","publisher":"Yahoo","summary":"OPKO Health's (OPK) potential in Rayaldee raises optimism about the stock.","url":"https://finance.yahoo.com/news/heres-why-retain-opko-health-152000750.html"},{"category":"company","date":1701960480,"headline":"Veeva Systems (VEEV) Beats on Q3 Earnings, Revises FY24 Outlook","id":124366634,"image":"https://media.zenfs.com/en/zacks.com/f8e8dd74fec7b16eb85235be391efa80","symbol":"ITGR","publisher":"Yahoo","summary":"Veeva Systems' (VEEV) fiscal Q3 results reflect impressive performances by both segments.","url":"https://finance.yahoo.com/news/veeva-systems-veev-beats-q3-144800929.html"},{"category":"company","date":1701876120,"headline":"3 Reasons to Retain AMN Healthcare (AMN) Stock in Your Portfolio","id":124344557,"image":"https://media.zenfs.com/en/zacks.com/c8704ffaba0234da981fa842a48f77b5","symbol":"ITGR","publisher":"Yahoo","summary":"Investors remain optimistic about AMN Healthcare's (AMN) broad array of services.","url":"https://finance.yahoo.com/news/3-reasons-retain-amn-healthcare-152200389.html"},{"category":"company","date":1701872640,"headline":"HealthEquity (HQY) Q3 Earnings Surpass Estimates, Margins Up","id":124344558,"image":"https://media.zenfs.com/en/zacks.com/f8e8dd74fec7b16eb85235be391efa80","symbol":"ITGR","publisher":"Yahoo","summary":"HealthEquity (HQY) witnesses solid growth in HSAs, besides recording robust performances in the majority of its segments, in the third quarter of fiscal 2024.","url":"https://finance.yahoo.com/news/healthequity-hqy-q3-earnings-surpass-142400239.html"},{"category":"company","date":1701866040,"headline":"Accuray (ARAY) Launches VitalHold in Japan for Use With Radixact","id":124341870,"image":"https://media.zenfs.com/en/zacks.com/072f196a59327977f5ceaaafb40567a1","symbol":"ITGR","publisher":"Yahoo","summary":"Accuray's (ARAY) VitalHold is likely to transform breast cancer treatment in Japan by integrating SGRT for precise radiotherapy. It may become a game-changer for patients and medical staff.","url":"https://finance.yahoo.com/news/accuray-aray-launches-vitalhold-japan-123400746.html"},{"category":"company","date":1701803880,"headline":"BD (BDX) Launches Advanced Vascular Access Management System","id":124321367,"image":"https://media.zenfs.com/en/zacks.com/62b53c8baa0ab2c805e2a16ae76ef3b8","symbol":"ITGR","publisher":"Yahoo","summary":"BD's (BDX) SiteRite 9 Ultrasound System is likely to revolutionize vascular care by enhancing clinician efficiency and setting a new standard in first-attempt success.","url":"https://finance.yahoo.com/news/bd-bdx-launches-advanced-vascular-191800949.html"},{"category":"company","date":1701795540,"headline":"West Pharmaceutical's (WST) New Launch to Expand Portfolio","id":124309102,"image":"https://media.zenfs.com/en/zacks.com/41b7bdd28f63138df08f17b665d3589a","symbol":"ITGR","publisher":"Yahoo","summary":"West Pharmaceutical's (WST) latest addition to its portfolio is likely to address the critical need for more drug preparation and delivery options at the point of care.","url":"https://finance.yahoo.com/news/west-pharmaceuticals-wst-launch-expand-165900832.html"},{"category":"company","date":1701713100,"headline":"Community Health (CYH) Sells Three Florida Facilities for $294M","id":124289451,"image":"https://media.zenfs.com/en/zacks.com/9752031dabc84079fccfebaf63c9eff9","symbol":"ITGR","publisher":"Yahoo","summary":"Community Health (CYH) divests three hospitals in Florida to Tampa General Hospital, substantiating its endeavor to intensify its focus on high-growth business areas.","url":"https://finance.yahoo.com/news/community-health-cyh-sells-three-180500603.html"},{"category":"company","date":1701709740,"headline":"Here's Why You Should Invest in Haemonetics (HAE) Right Now","id":124281761,"image":"https://media.zenfs.com/en/zacks.com/b35c1538fbd501bfb8e20b349661fde7","symbol":"ITGR","publisher":"Yahoo","summary":"Investors are optimistic about Haemonetics (HAE) on consistent growth performance and raised guidance.","url":"https://finance.yahoo.com/news/heres-why-invest-haemonetics-hae-170900473.html"},{"category":"company","date":1701697980,"headline":"McKesson (MCK) Announces Availability of FDA-Cleared Drug","id":124278101,"image":"https://media.zenfs.com/en/zacks.com/c8704ffaba0234da981fa842a48f77b5","symbol":"ITGR","publisher":"Yahoo","summary":"The availability of the FDA-approved drug via McKesson's (MCK) independent specialty pharmacy is expected to give patients more treatment options for breast cancer.","url":"https://finance.yahoo.com/news/mckesson-mck-announces-availability-fda-135300516.html"}]}